HeartFlow, Inc. (HTFL)
NASDAQ: HTFL · Real-Time Price · USD
27.53
-1.41 (-4.87%)
Dec 5, 2025, 4:00 PM EST - Market closed
HeartFlow Employees
HeartFlow had 626 employees as of December 31, 2024.
Employees
626
Change
n/a
Growth
n/a
Revenue / Employee
$258,596
Profits / Employee
-$200,273
Market Cap
2.34B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 626 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HTFL News
- 5 days ago - Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO - The Motley Fool
- 15 days ago - Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million - The Motley Fool
- 16 days ago - Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 18 days ago - Where Innovation Meets the Heart: Stanford's New Position in HeartFlow - The Motley Fool
- 23 days ago - Heartflow Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 24 days ago - Baron Technology Fund: AI Update - Seeking Alpha
- 26 days ago - AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification - GlobeNewsWire
- 4 weeks ago - Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 - GlobeNewsWire